|
POLA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.67839999995778E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.90929999999545E-05 |
| Normal-vs-Stage2 |
8.944800E-03 |
| Normal-vs-Stage3 |
3.86989999999754E-05 |
| Normal-vs-Stage4 |
8.07119999945982E-07 |
| Stage1-vs-Stage2 |
9.777000E-01 |
| Stage1-vs-Stage3 |
3.306000E-01 |
| Stage1-vs-Stage4 |
3.140300E-02 |
| Stage2-vs-Stage3 |
6.112400E-01 |
| Stage2-vs-Stage4 |
2.141600E-01 |
| Stage3-vs-Stage4 |
2.778800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76310000005375E-06 |
| Normal-vs-AfricanAmerican |
2.835000E-01 |
| Normal-vs-Asian |
2.337200E-03 |
| Caucasian-vs-AfricanAmerican |
5.802300E-02 |
| Caucasian-vs-Asian |
6.069600E-01 |
| AfricanAmerican-vs-Asian |
1.966410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1872999999829E-06 |
| Normal-vs-Female |
6.00699999999676E-05 |
| Male-vs-Female |
1.203210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.993200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.93440000000522E-05 |
| Normal-vs-Age(61-80Yrs) |
1.53448999999917E-05 |
| Normal-vs-Age(81-100Yrs) |
7.922400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.446600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.144620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.724600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.912000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.178000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.255000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.220300E-02 |
| Classical-VS-Follicular |
5.218700E-04 |
| Classical-VS-Other |
1.555450E-01 |
| Classical-VS-Normal |
1.119630E-03 |
| Tall-VS-Follicular |
7.097400E-01 |
| Tall-VS-Other |
6.228800E-01 |
| Tall-VS-Normal |
1.635630E-04 |
| Follicular-VS-Other |
7.985400E-01 |
| Follicular-VS-Normal |
2.72710000026599E-07 |
| Other-VS-Normal |
1.040420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.05920000000615E-05 |
| Normal-vs-N1 |
1.78353999999992E-05 |
| N0-vs-N1 |
3.367000E-01 |
|
|
